NHI HUYNH: Open Payments
NPI 1710066642 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 9 payments from 8 companies in 2025. Trend: 2023 $973 · 2024 $1,428 · 2025 $916
Food & beverage: $844Education: $73
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $250 |
| Gilead Sciences, Inc. | 1 | $150 |
| SANOFI-AVENTIS U.S. LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $122 |
| Aimmune Therapeutics, Inc. | 1 | $119 |
| Teva Pharmaceuticals USA, Inc. | 1 | $73 |
| Madrigal Pharmaceuticals | 1 | $61 |
| Alkermes, Inc. | 1 | $17 |
Products named: Wegovy, Ozempic, TZIELD, MOUNJARO, ZENPEP, REZDIFFRA, ARISTADA.
Industry payments across CA — which companies pay providers there.
